Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes
Greta Anschuetz1, Lenore Asbel, Melinda E Salmon
1From the *Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, PA; and †Division of STD Prevention, US. Centers for Disease Control and Prevention, Atlanta, GA.
Abstract:
After 2 notices with treatment recommendation changes for Neisseria gonorrhoeae, the Philadelphia Department of Public Health documented medical therapy for 92% (3279/3551) of cases; 3001 (92%) received a recommended therapy. Nonrecommended therapies were documented in 8% of cases. Providers diagnosing 2 or less N. gonorrhoeae cases were more likely to use nonrecommended therapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis I: Introduction
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

